Prevalence of pulmonary hypertension in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 23, Issue 4, 2005, Pages 447-454

  de Azevedo, Ana Baetriz Cordeiro ^a,c,d   Sampaio Barros, Percival D ^b,c   Torres, Rosália Moraes ^a   Moreira, Caio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Brazilian Society of Cardiology   (Brazil)

^d NONE   (Brazil)

Author keywords

Echocardiography; Pulmonary hypertension; Systemic sclerosis

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOPULMONARY HEMODYNAMICS; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; COR PULMONALE; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DOPPLER ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEALTH SERVICE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BRAZIL; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREVALENCE; PULMONARY ARTERY; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC;

EID: 26844478746     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. WIGLEY FM: Clinical features of systemic sclerosis. In KLIPPEL JH, DIEPPE PA (Eds.): Rheumatology. 2nd ed., Mosby, London 1998; 7:9.1-14.
2. NISHIOKA K, KATAYAMA I, KONDO H et al.: Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). J Dermatol 1996; 23: 677-82.
3. SIMEON CP, ARMADANS L, FONOLLOSA V et al.: Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis 1997; 56: 723-8.
4. JACOBSEN S, HALBERG P, ULLMAN S: Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998; 37: 750-5.
5. HESSELSTRAND, R, SCHEJA A, AKESSON A: Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998; 57: 682-6.
6. ENGLERT H, O'CONNOR H, SMALL-McMAHON J: Systemic sclerosis prevalence and mortality in Sydney 1974-88. Aust NZJ Med 1999; 29: 42-50.
7. VLACHOYIANNOPOULOS PG, DAFNI UG, PAKAS I et al.: Systemic sclerosis in Greece: low mortality and strong linkage with HLA-DRB1*1104. Ann Rheum Dis 2000;59:359-67.
8. FOELDVARI I, ZHAVANIA M, BIRDI N et al.: Favorable outcome in 135 children with juvenile systemic sclerosis: results of a multinational survey. Rheumatology 2000; 39: 556-9.
9. REVEILLE JD, FISCHBACH M, McNEARMEY T et al.: Systemic sclerosis in three U.S. ethnic groups: a comparison of clinical, sociodemographic, serologic and immunogenetic determinants. Semin Arthritis Rheum 2001; 30: 332-46.
10. FERRI C, VALENTINI G, COZZI F et al.: Systemic sclerosis: demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 2002; 81: 139-53.
11. SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD JP et al.: Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002; 81: 154-67.
12. DENTON CP, BLACK CM: Pulmonary vascular involvement in systemic sclerosis. In CLEMENTS PJ, FURST DE (Eds.): Systemic Sclerosis. 2nd ed., Lippincott Williams & Wilkins, Philadelphia 2004: 184-94.
13. DENTON CP, BLACK CM: Pulmonary hypertension in systemic sclerosis. Rheum Dis Clin North Am 2003; 29: 371-90.
14. DENTON CP, CAILES JB, PHILLIPIS GD, WELLS AU, BLACK CM, DU BOIS RM: Comparison of Doppler echocardiography and right heart catheterization in systemic sclerosis. Br J Rheumatol 1997; 36: 239-43.
15. GIBBS JSR: Recommendations on the management of pulmonary hypertension in clinical practice. British Cardiac Society Guidelines and Medical Practice Committee, and approved by the British Thoracic Society and the British Society of Rheumatology. Heart 2001; 86 (Suppl. i): I1-I13.
16. MCGOON M, GUTTERMAN D, STEEN V et al.: Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (Suppl.): I14-I34.
17. MUKERJEE D, ST. GEORGE D, KNIGHT C et al.: Echocardiography and pulmonary function as screening tests for pulmonary hypertension in systemic sclerosis. Rheumatology 2004; 43: 461-6.
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
19. LeROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
20. ALARCÓN-SEGOVIA D, CARMEL MH: Comparison between 3 diagnostic criteria for mixed connective tissue disease: Study of 593 patients. J Rheumatol 1989; 16: 328-34.
21. OTTO CM: Textbook of Clinical Echocardiography. 2nd ed., W.B. Saunders, Philadelphia-EUA, 2000.
22. I Brazilian Congress on Spirometry. J Bras Pneumol 1996; 22: 105-64.
23. STEEN V: Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis 2003; 62: 97-9.
24. MATUCCI-CERINIC M, D'ANGELO S, DENTON CP, VLACHOYIANNOPOULOS P, SILVER R: Assessment of lung involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S19-S23.
25. MAGLIANO M, ISENBERG DA, HILLSON J: Pulmonary hypertension in autoimmune rheumatic diseases. Where are we now? Arthritis Rheum 2002; 46: 1997-2009.
26. VANCHEESWARAN R, MAGOULAS T, EFRAT G et al.: Circulating endothelin-1 levels in systemic sclerosis subsets - a marker of fibrosis or vascular dysfunction? J Rheumatol 1994; 21: 1838-44.
27. MITRI GM, LUCAS M, FERTIG N, STEEN VD, MEDSGER TA Jr: A comparison between anti-Th/To and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003; 48: 203-9.
28. SACKS DG, OKANO Y, STEEN VD, CURTISS E, SHAPIRO LS, MEDSGER TA Jr: Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 1996; 23: 639-42.
29. STEEN V, MEDSGER TA JR: Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 516-22.
30. YAMANE K, IHN H, ASANO Y et al.: Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology 2000; 39: 1269-71.
31. STEEN V, CONTE C, OWENS G, MEDSGER TA Jr: Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994; 37: 1283-9.
32. MORGAN C, KNIGHT C, LUNT M, BLACK CM, SILMAN AJ: Predictors of end stage lung disease in a cohort of patients with scleroderma. Ann Rheum Dis 2003; 62: 146-50.
33. SACKNER MA, HEINZ ER, STEINBERG AJ: The heart in scleroderma. Am J Cardiol 1966; 17: 542-59.
34. STUPI AM, STEEN V, OWENS GR, BARNES EL, RODNAN GP, MEDSGER TA Jr: Pulmonary hypertension in the crest syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515-24.
35. SAMPAIO-BARROS PD, LEME Jr. CA, MARQUES NETO JF: Valor do ecocardiograma com "doppler" na esclerose sistêmica. Braz J Rheumatol 1995; 35: 327-31.
36. KOH ET, LEE P, GLADMAN DD, ABUSHAKRA M: Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996; 35: 989-93.
37. BATTLE RW, DAVITT MA, COOPER SM et al.: Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996; 110: 1515-9.
38. MURATA I, TAKENAKA K, YOSHINOYA S et al.: Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Chest 1997; 111: 36-43.
39. MacGREGOR AJ, CANAVAN R, KNIGHT C et al.: Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology 2001; 40: 453-9.
40. MUKERJEE D, St GEORGE D, COLEIRO B et al.: Prevalence and outcome in systemic sclerosis associated with pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93.
41. MERKEL PA, CLEMENTS PJ, REVEILLE JD, SUAREZ-ALMAZOR ME, VALENTINI G, FURST DE: Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 2003; 30: 1630-47.